Myalept - Ownership and Business Overview

Medical ProductsCompany

Myalept Ownership

Who owns Myalept?

Myalept is owned by Aegerion Pharmaceuticals. It was acquired on November 6, 2014.

Myalept Business Overview

Where is Myalept headquartered?

Myalept is headquartered in United States.

What sector is Myalept in?

Myalept is a medical products company.

Medical Products M&A Summary in 2014

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2014. The largest medical products acquisition in 2014 was Covidien - which was acquired by Medtronic for $42.9B.

Join Mergr to view all 217 acquisitions of medical products companies in 2014, including 24 acquisitions by private equity firms, and 193 by strategics.

Myalept


United States,
(855) 669-2537
www.myaleptrems.com

Myaleptâ„¢ (metreleptin for injection) is an orphan product that is indicated to treat complications of leptin deficiency in patients with generalized lipodystrophy.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.